Evoke Pharma Receives Market Exclusivity for its Nasal Spray
Evoke Pharma, Inc. (NASDAQ: EVOK) today announced that it has been granted new drug product exclusivity by the U.S. Food and Drug Administration (FDA) for GIMOTI (metoclopramide) nasal spray. Shares up 225% Shares of Evoke Pharma, Inc. (NASDAQ: EVOK) surged...